Study on the Immediate Analgesic Effect of Yanglingquan Acupoint Treatment for Biliary Colic

Study on the Immediate Analgesic Effect of Yanglingquan Acupoint Treatment for Biliary Colic

Guided by traditional meridian and acupoint theory, conducting standardized, large-sample, multicenter randomized controlled trials (RCTs) to evaluate the clinical efficacy of pattern differentiation and meridian-based acupoint selection for biliary colic across multiple levels can provide high-quality research evidence for developing evidence-based guidelines or optimal treatment protocols. This holds significant importance for enhancing the clinical efficacy of acupuncture in treating biliary colic and promoting its widespread clinical application. Therefore, this study will conduct a multicenter, large-sample randomized controlled trial comparing the clinical effects of acupuncture at Yanglingquan (GB34) versus drug therapy for acute cholecystitis biliary colic. It aims to investigate the clinical efficacy and safety of acupuncture treatment for acute cholecystitis biliary colic.

Inclusion Criteria:

• Meets diagnostic criteria for cholecystitis according to both Chinese and Western medicine;
• Patients exhibiting clinical manifestations of biliary colic with a Visual Analogue Scale (VAS) score >4;
• Aged 18 to 65 years;
• Patients provide informed consent and voluntarily participate in this study.

Exclusion Criteria:

• Patients meeting criteria for emergency surgery;
• Patients with psychiatric issues unable to cooperate with treatment;
• Patients with severe complications such as suppurative cholecystitis, suppurative cholangitis, acute pancreatitis, gallbladder perforation, tumors, or severe infections;
• Patients with other serious comorbidities including liver, brain, kidney, or cardiovascular diseases;
• Patients with severe local lesions (e.g., infections, burns, scalds) where acupuncture is contraindicated;
• Pregnant women and lactating women;
• Patients who have already undergone other treatment modalities.